MPH

Westat Names Terry Moore Vice President of Innovation and Quality

Retrieved on: 
Wednesday, December 13, 2023

ROCKVILLE, Md., Dec. 13, 2023 /PRNewswire/ -- Westat, a leading provider of research, statistical, and professional services, today announced that Terry Moore, MPH, will join the company on January 1, 2024, as Vice President of Innovation and Quality. In this role, Moore will oversee and enhance processes to further align Westat with industry best practices in the full lifecycle of project and risk management, talent development, and quality assurance to meet client requirements.

Key Points: 
  • ROCKVILLE, Md., Dec. 13, 2023 /PRNewswire/ -- Westat, a leading provider of research, statistical, and professional services, today announced that Terry Moore, MPH , will join the company on January 1, 2024, as Vice President of Innovation and Quality.
  • Throughout her 30-year career, Moore has led goal-focused teams on high-visibility projects related to program evaluation, implementation, and quality measurement and improvement.
  • Her research expertise, leadership skills, and commitment to collaboration and open communication will help drive continued innovation and excellence at Westat.
  • "We look forward to the success we will achieve under her leadership of our innovation and quality efforts."

SOLLIS HEALTH ANNOUNCES NEW CHIEF OPERATING OFFICER

Retrieved on: 
Wednesday, December 13, 2023

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Sollis Health, the first and only concierge urgent and emergency care provider, has named Jia Jia Ye as Chief Operating Officer, effective immediately. As the company's COO, Ye will ensure that Sollis Health delivers unparalleled clinical quality and member experience, with the brand's continued national expansion and growth.

Key Points: 
  • Medical concierge provider taps former Oscar Health and One Medical Executive, Jia Jia Ye
    NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Sollis Health , the first and only concierge urgent and emergency care provider, has named Jia Jia Ye as Chief Operating Officer, effective immediately.
  • As the company's COO, Ye will ensure that Sollis Health delivers unparalleled clinical quality and member experience, with the brand's continued national expansion and growth.
  • "I am confident that with Jia Jia's expertise, Sollis Health will continue delivering the highest quality of care and capability."
  • "I'm thrilled to join Sollis Health and help expand our reach, bringing top-tier clinical care and an exceptional member experience to more people," said Ye.

Highmark Health releases findings from "How's It Going?" behavioral health survey

Retrieved on: 
Tuesday, December 12, 2023

PITTSBURGH, Dec. 12, 2023 /PRNewswire-PRWeb/ -- Highmark Health asked western Pennsylvanians "How's it going?" in a questionnaire to gauge sentiment around behavioral health, and nearly two-thirds (64 percent) of respondents indicated they were struggling in some way, with stress levels noted as the largest concern.

Key Points: 
  • We encourage our members and patients to view their health holistically, being mindful of how physical and social health play a role in their mental health."
  • Highmark is offering behavioral health resources on its website, which are free for everyone.
  • Mental Well-Being powered by Spring Health was announced as a part of the My Highmark member portal in October 2023.
  • "Highmark's Mental Well-Being program will increase access to virtual and in-person behavioral health services by 40 percent—across our entire footprint," said Anil Singh, MD, MPH, SVP and executive medical director, population and curated health, Highmark Health.

New Study Explores Ways to Reduce Inflammation and Preserve Bone Health with Prunes

Retrieved on: 
Tuesday, December 12, 2023

ROSEVILLE, Calif., Dec. 12, 2023 /PRNewswire/ -- A new study published in The Journal of Nutrition shows daily consumption of prunes may reduce inflammation markers connected to bone signaling pathways and reduce the effects of bone loss among postmenopausal women.

Key Points: 
  • ROSEVILLE, Calif., Dec. 12, 2023 /PRNewswire/ -- A new study published in The Journal of Nutrition shows daily consumption of prunes may reduce inflammation markers connected to bone signaling pathways and reduce the effects of bone loss among postmenopausal women.
  • It's important to have a better understanding of how non-pharmacological approaches – like lifestyle and dietary choices—can also impact the progression and mitigation of bone loss."
  • This is an ancillary study of a larger, single-center, parallel-arm, 12-month randomized control trial1 (PRUNE study).
  • This investigation was completed by 183 participants who were split into three groups: control/no prunes (n=70), 50 grams/day prunes (n=67) and 100 grams/day prunes (n=46).

NEA AWARDS GRANTS FOR ECZEMA RESEARCH TOTALING NEARLY $1 MILLION

Retrieved on: 
Tuesday, December 12, 2023

NOVATO, Calif., Dec. 12, 2023 /PRNewswire/ -- The National Eczema Association (NEA) today announced the recipients for its 2023 research grants. From both U.S.-based and international applications, the research projects of 18 outstanding investigators were selected, representing grants totaling nearly $1 million. NEA's commitment to innovative eczema research has continued to expand with an increasing number of yearly awardees and an annual investment that has nearly tripled over the past three years.  

Key Points: 
  • From both U.S.-based and international applications, the research projects of 18 outstanding investigators were selected, representing grants totaling nearly $1 million.
  • NEA's commitment to innovative eczema research has continued to expand with an increasing number of yearly awardees and an annual investment that has nearly tripled over the past three years.
  • With 2023 marking the 20th anniversary of its grantmaking, NEA has invested nearly $4 million since its first grant was awarded in 2004.
  • The 2023 research grants were awarded as follows:
    Champion Research Grant– Encourages proven researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema.

Real World Data Shows Impact of Immunotherapy in Populations Underrepresented in Clinical Trials, According to JNCCN Study

Retrieved on: 
Monday, December 11, 2023

PLYMOUTH MEETING, Pa., Dec. 11, 2023 /PRNewswire/ -- New research in the December 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds patients treated with first-line immunotherapy for advanced Non-Small Cell Lung Cancer (NSCLC) showed similar results in terms of survival, progression-free survival, and treatment duration, regardless of race or ethnicity, even with differences in income and insurance. The clinical investigators focused on patients in under-represented groups who were typically less likely to be included in the immunotherapy clinical trials that have been conducted to date. They analyzed results from 248 patients treated with pembrolizumab over a 9-year period between January 1, 2013 and June 1, 2022, with non-Hispanic Black, Hispanic, and Non-Hispanic White patients each accounting for an approximately equal percentage. Median overall survival was 16.8 to 26.3 months, similar to results previously reported in large prospective clinical trials.

Key Points: 
  • The clinical investigators focused on patients in under-represented groups who were typically less likely to be included in the immunotherapy clinical trials that have been conducted to date.
  • Median overall survival was 16.8 to 26.3 months, similar to results previously reported in large prospective clinical trials.
  • This study could change how we take care of patients and plan future lung cancer studies to better include all patients.
  • "There is a clear need for future studies to include underrepresented patient groups in clinical trials to validate these findings and to better guide clinical practice."

CDC's Fall and Winter Virus Season Communications Effort Appeals to What We Hold Dearest

Retrieved on: 
Monday, December 11, 2023

ATLANTA, Dec. 11, 2023 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) has a new communications effort to address the anticipated increase of flu, COVID-19, and RSV cases this fall and winter virus season. Similar respiratory disease activity in recent years has resulted in high hospitalization and mortality rates in the United States, highlighting the critical need for clear communications around virus prevention to help Americans protect their health.

Key Points: 
  • ATLANTA, Dec. 11, 2023 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) has a new communications effort to address the anticipated increase of flu, COVID-19, and RSV cases this fall and winter virus season.
  • "As we head into this respiratory virus season, we are starting from a place of strength.
  • Creative elements encourage vaccination and other preventive steps during fall and winter gathering season, while also increasing awareness and perception of severity of respiratory diseases.
  • Today's fall and winter virus season challenges require collaboration and coordination with a wide variety of partners to advance essential information that helps protect communities against the worst of these respiratory viruses.

The Inner Circle Acknowledges, Reginald D. Hughes as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine

Retrieved on: 
Friday, December 8, 2023

LAURELTON, N.Y., Dec. 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Reginald D. Hughes, MD, MPH, FAAFP, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine.

Key Points: 
  • LAURELTON, N.Y., Dec. 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Reginald D. Hughes, MD, MPH, FAAFP, is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Family Medicine.
  • He completed a residency in family medicine and a fellowship in family medicine/obstetrics, both completed at Jamaica Hospital Medical Center in Queens, NY from 1998 to 2001.
  • The doctor also holds an MPH (public health) and a Master's degree in space studies (astronomy) from the American Military University.
  • The doctor noted that family medicine is a medical specialty devoted to comprehensive health care for people of all ages.

Stamford Hospital is Recognized by U.S. News & World Report for Maternity Care

Retrieved on: 
Friday, December 8, 2023

STAMFORD, Conn., Dec. 8, 2023 /PRNewswire/ -- This week, U.S. News & World Report (USNWR) named Stamford Hospital as a High Performing Hospital for Maternity in its "Best Hospitals for Maternity in 2024" ratings. This is Stamford Hospital's first appearance on the list, and they are one of only two hospitals in Connecticut and the only hospital in Fairfield County to earn this distinction. This follows a recent recognition from Centers for Medicare and Medicaid Services for Stamford Hospital as "birthing-friendly."

Key Points: 
  • STAMFORD, Conn., Dec. 8, 2023 /PRNewswire/ -- This week, U.S. News & World Report (USNWR) named Stamford Hospital as a High Performing Hospital for Maternity in its "Best Hospitals for Maternity in 2024" ratings.
  • This follows a recent recognition from Centers for Medicare and Medicaid Services for Stamford Hospital as "birthing-friendly."
  • 680 hospitals submitted maternity data to USNWR and less than 50% earned recognition for maternity care.
  • I extend my congratulations to the Stamford Health team on this well-deserved recognition from U.S. News & World Report."

GIE Medical Announces First Patient Enrolled in PATENT-E Benign Esophageal Stricture Treatment Study

Retrieved on: 
Thursday, December 7, 2023

MINNEAPOLIS, Dec. 7, 2023 /PRNewswire/ -- GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, announced today that enrollment has begun in its Paclitaxel Coated Balloon for the Treatment of Chronic Benign Stricture - Esophagus (PATENT-E) study. The study is evaluating the safety and efficacy of the first of its kind ProTractX3™ TTS drug coated balloon (DCB) and the first patient was enrolled at the University of North Carolina School of Medicine.

Key Points: 
  • MINNEAPOLIS, Dec. 7, 2023 /PRNewswire/ -- GIE Medical , a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, announced today that enrollment has begun in its Paclitaxel Coated Balloon for the Treatment of Chronic Benign Stricture - Esophagus (PATENT-E) study.
  • The study is evaluating the safety and efficacy of the first of its kind ProTractX3™ TTS drug coated balloon (DCB) and the first patient was enrolled at the University of North Carolina School of Medicine.
  • "We are pleased to be enrolling the randomized cohorts in PATENT-E, our treatment for esophageal stricture IDE study, and look forward to the results," said GIE Medical Vice President Drew McClure.
  • "We sincerely thank our clinical partners and internal GIE Medical team for achieving this significant milestone."